FY2025 Earnings Forecast for Allogene Therapeutics, Inc. Issued By Zacks Research (NASDAQ:ALLO)
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Rating) – Investment analysts at Zacks Research issued their FY2025 earnings per share (EPS) estimates for Allogene Therapeutics in a report released on Tuesday, March 14th. Zacks Research analyst S. Ganoria anticipates that the company will earn ($2.61) per share for the year. The consensus estimate for Allogene Therapeutics’ […]